<DOC>
	<DOCNO>NCT01130584</DOCNO>
	<brief_summary>The purpose study determine pyruvate kinase M2 ( PKM2 ) use biomarker cancer . Pyruvate kinase M2 elevate malignant pleural fluid plasma , may useful biomarker distinguish malignant non-malignant cause pleural effusion . In addition , pyruvate kinase M2 also find elevated saliva cancer patient compare control . Measuring pyruvate kinase M2 saliva may use diagnose cancer monitor treatment progress cancer .</brief_summary>
	<brief_title>Pyruvate Kinase Isoform M2 ( PKM2 ) Possible Biomarker Cancer</brief_title>
	<detailed_description />
	<criteria>Any cancer patient pleural effusion drain indwell chesttube inpatient ward . Patient pleural effusion proven cancer whose pleural effusion know malignant .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2013</verification_date>
	<keyword>Cancer Patients</keyword>
</DOC>